A new study has found that U.S. poison control centers received a significantly higher number of calls about semaglutide after the drug was approved for weight loss. The research, reported by News-Medical, tracked a surge in reports of side effects and accidental exposures tied to the medication, which is also used for type 2 diabetes.

Key takeaways

  • Poison control center calls about semaglutide rose sharply after the FDA approved it for weight management.
  • The increase in calls suggests a rise in both intentional misuse and accidental exposure to the drug.
  • Researchers call for better patient education and monitoring as semaglutide use expands.

What the study found

Researchers analyzed data from U.S. poison control centers and found that calls involving semaglutide, the active ingredient in drugs like Ozempic and Wegovy, increased substantially after the 2021 approval for weight loss. The study did not detail specific numbers but indicated a clear trend linked to the drug’s wider availability.

The calls included reports of side effects such as nausea, vomiting, and more serious issues like accidental overdoses. The authors of the original report note that the pattern mirrors the rise in semaglutide prescriptions for weight loss, which have soared since the approval.

Why this matters

Semaglutide belongs to a class of drugs called GLP-1 receptor agonists. While it is effective for diabetes and weight loss, its growing use for cosmetic weight loss has raised concerns about safety. The study highlights that as more people use these drugs, the risk of adverse events and misuse may increase.

The researchers emphasize that poison control data offers a real-world snapshot of drug safety. They suggest that healthcare providers should educate patients about proper use and storage to prevent accidental ingestion, especially by children.

Frequently Asked Questions

What is semaglutide?

Semaglutide is a medication originally developed for type 2 diabetes. It is also sold under brand names like Wegovy for weight loss. It works by mimicking a hormone that regulates appetite and blood sugar.

Why are poison control calls increasing?

The study links the rise in calls to the drug’s approval for weight loss. As more people use semaglutide, there are more reports of side effects, accidental overdoses, and misuse, which trigger calls to poison centers.

What should patients do to stay safe?

Patients should follow their doctor’s instructions carefully, store the medication out of reach of children, and report any unusual symptoms immediately. The study’s authors advise that increased awareness can help prevent serious incidents.

This is an original report by Vital Signs Today, informed by reporting from Google News. Read the original source.

This article is for information only and is not medical advice. See our Medical Disclaimer.